EverSource Wealth Advisors LLC Raises Stock Holdings in HealthEquity, Inc. $HQY

EverSource Wealth Advisors LLC boosted its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 50.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 49,264 shares of the company’s stock after buying an additional 16,588 shares during the quarter. EverSource Wealth Advisors LLC owned 0.06% of HealthEquity worth $4,669,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in HQY. Sivia Capital Partners LLC purchased a new stake in HealthEquity during the second quarter worth about $306,000. Cullen Frost Bankers Inc. grew its holdings in shares of HealthEquity by 172.3% in the second quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock valued at $37,000 after purchasing an additional 224 shares in the last quarter. Ethic Inc. increased its stake in HealthEquity by 36.2% during the 2nd quarter. Ethic Inc. now owns 6,870 shares of the company’s stock worth $721,000 after buying an additional 1,826 shares during the period. Caitong International Asset Management Co. Ltd acquired a new stake in HealthEquity during the 2nd quarter worth approximately $33,000. Finally, Oppenheimer Asset Management Inc. boosted its position in HealthEquity by 42.2% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 106,922 shares of the company’s stock valued at $11,201,000 after buying an additional 31,716 shares during the period. 99.55% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

HQY has been the topic of a number of recent research reports. JPMorgan Chase & Co. upped their price objective on HealthEquity from $126.00 to $129.00 and gave the stock an “overweight” rating in a research report on Thursday, December 4th. The Goldman Sachs Group cut HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 target price for the company. in a research note on Friday, January 9th. Jefferies Financial Group set a $108.00 price target on HealthEquity in a research report on Thursday. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $120.00 price objective on shares of HealthEquity in a research note on Friday, December 5th. Finally, Citizens Jmp set a $122.00 target price on shares of HealthEquity in a research note on Thursday, December 4th. One analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $113.87.

Insider Buying and Selling at HealthEquity

In related news, EVP Elimelech Rosner sold 10,959 shares of the stock in a transaction on Thursday, December 18th. The shares were sold at an average price of $95.45, for a total value of $1,046,036.55. Following the transaction, the executive vice president directly owned 45,742 shares of the company’s stock, valued at $4,366,073.90. This trade represents a 19.33% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Delano Ladd sold 1,500 shares of the business’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $94.72, for a total transaction of $142,080.00. Following the completion of the sale, the executive vice president directly owned 73,979 shares of the company’s stock, valued at approximately $7,007,290.88. This trade represents a 1.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 1.50% of the company’s stock.

HealthEquity Trading Down 3.8%

NASDAQ:HQY opened at $75.87 on Tuesday. HealthEquity, Inc. has a 1 year low of $72.76 and a 1 year high of $116.65. The stock has a market cap of $6.48 billion, a P/E ratio of 34.80, a P/E/G ratio of 0.98 and a beta of 0.24. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13. The stock has a 50-day simple moving average of $86.15 and a 200-day simple moving average of $91.57.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.11. The firm had revenue of $322.16 million during the quarter, compared to analysts’ expectations of $320.92 million. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The firm’s revenue was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.78 earnings per share. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.